NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The rivaling AI companies pushed GPT-5.3-Codex and Claude Opus 4.6, and had back-to-back appearances on a tech and business podcast.Read More